Renin–angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials | Zendy

AI Assistant Blog Pricing

Renin–angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.